Fresenius Medical Care AG
SWB:FME

Watchlist Manager
Fresenius Medical Care AG Logo
Fresenius Medical Care AG
SWB:FME
Watchlist
Price: 38.83 EUR 1.78% Market Closed
Market Cap: €22.8B

Net Margin

3.7%
Current
Improving
by 0.7%
vs 3-y average of 3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
3.7%
=
Net Income
€718.2m
/
Revenue
€19.6B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
3.7%
=
Net Income
€718.2m
/
Revenue
€19.6B

Peer Comparison

Country Company Market Cap Net
Margin
DE
Fresenius Medical Care AG
XMUN:FME
23.3B EUR
Loading...
US
CVS Health Corp
NYSE:CVS
95.7B USD
Loading...
US
Cigna Group
XMUN:CGN
61.7B EUR
Loading...
US
Cigna Corp
NYSE:CI
72.6B USD
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.9B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
23B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.9B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.4B EUR
Loading...
US
Guardant Health Inc
NASDAQ:GH
12.9B USD
Loading...
US
DaVita Inc
NYSE:DVA
10.3B USD
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
10.8B AUD
Loading...

Market Distribution

In line with most companies in Germany
Percentile
59th
Based on 3 835 companies
59th percentile
3.7%
Low
-222 027.4% — -2%
Typical Range
-2% — 6%
High
6% — 85 055.6%
Distribution Statistics
Germany
Min -222 027.4%
30th Percentile -2%
Median 2.2%
70th Percentile 6%
Max 85 055.6%

Fresenius Medical Care AG
Glance View

Fresenius Medical Care AG, a titan in the realm of healthcare, traces its origins back to Germany, where its journey began with an unwavering dedication to improving the lives of individuals suffering from chronic kidney failure. This imperative mission is at the core of its operations, merging compassionate patient care with cutting-edge technologies. As the leading provider of dialysis products and services globally, Fresenius Medical Care operates a vast network of renal care facilities, spanning continents, and serves a diverse patient base. The company designs and manufactures a comprehensive range of dialysis machines and related products, which are crucial to the life-sustaining process of cleansing blood when kidneys fail to function effectively. This seamless integration of service provision and product innovation underpins its success, creating a synergy that sets it apart in the healthcare sector. Revenue streams for Fresenius Medical Care are as diverse as they are robust, stemming from both its product line and its extensive network of clinics. The Clinics Division forms the backbone of its business model by offering treatment options directly to patients through a wide network of dialysis centers. Here, it garners revenue by billing healthcare providers and insurance companies for treatments administered. Meanwhile, its Products Division generates income by catering to both its proprietary clinics and third-party healthcare providers with dialysis equipment, consumables, and accompanying services. This dual-faceted structure ensures a steady flow of income, solidifying its position as an indispensable player in the global chronic kidney disease management landscape and making Fresenius Medical Care a stalwart in healthcare delivery systems worldwide.

FME Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
3.7%
=
Net Income
€718.2m
/
Revenue
€19.6B
What is Fresenius Medical Care AG's current Net Margin?

The current Net Margin for Fresenius Medical Care AG is 3.7%, which is above its 3-year median of 3%.

How has Net Margin changed over time?

Over the last 3 years, Fresenius Medical Care AG’s Net Margin has decreased from 4% to 3.7%. During this period, it reached a low of 2.3% on Sep 30, 2023 and a high of 4% on Sep 30, 2022.

Back to Top